Agoracom: Small Cap Investment - Awakn Life Sciences Corp. - Discussion Forum

Biotech Company With Clinical Operations Developing Psychedelic Medicine To Treat Addiction

First 3 UK Clinics Opened In 2021, Targeting 20 Clinics By 2024 ~$100M In Revenue

Sponsored

List Message View

Thread Message View

Message Title

Rating

Author / Date

END OF DAY ALERT: Awakn Life Sciences (AWKN: NEO) (AWKNF: OTCQB) Up 17% On 134K SHARES

Aug 15, 2022 04:20PM

Awakn Life Sciences Expands Commercial Operations into the U.S. - First Licensing Partnership Agreement with Revitalist

Aug 15, 2022 09:00AM

END OF DAY ALERT: Awakn Life Sciences (AWKN: NEO) (AWKNF: OTCQB) Up 33% On 69K SHARES

Jul 20, 2022 04:00PM

Re: Awakn Life Sciences' Phase III Trial Approved for Approximately CA$2.5 Million Funding from UK State Covering 66% of Costs

Jul 20, 2022 08:55AM

Awakn Life Sciences' Phase III Trial Approved for Approximately CA$2.5 Million Funding from UK State Covering 66% of Costs

Jul 20, 2022 08:24AM

Re: Awakn Life Sciences Appoints UK Leader in Addictions Psychiatry, Dr. Arun Dhandayudham, as Chief Medical Officer

Jul 18, 2022 02:50AM

Re: Awakn Life Sciences Initiates Follow-On Behavioral Study to Focus on Gambling Disorder

Jul 18, 2022 02:49AM

Awakn Life Sciences Provides a Business and Corporate Update

Jul 15, 2022 07:30AM

END OF DAY ALERT: Awakn Life Sciences (AWKN: NEO) (AWKNF: OTCQB) Up 15% On 68K SHARES

AGORACOM-Multimedia

Jul 05, 2022 04:00PM

Awakn Life Sciences Receives UK State Funding to Identify Optimal Pathway to Market in UK & US for Its Lead Clinical Development…

Jul 05, 2022 07:42AM

END OF DAY ALERT: Awakn Life Sciences (AWKN: NEO) (AWKNF: OTCQB) Up 18% On 23K SHARES

Jul 04, 2022 04:00PM

Re: Awakn Life Sciences to Participate in Upcoming May 2022 Conferences

Jun 22, 2022 11:20AM

Awakn Life Sciences to Present in Upcoming June 2022 Conferences

Jun 17, 2022 09:03AM

END OF DAY ALERT: Awakn Life Sciences (AWKN: NEO) (AWKNF: OTCQB) Up 29% On 81K SHARES

Jun 15, 2022 04:00PM

Awakn Life Sciences Reports Results for Quarter Ended April 30, 2022

Jun 14, 2022 04:00PM

Awakn Life Sciences Appoints Biotech and Investment Veteran Dennis Purcell as a Special Advisor to the CEO

Jun 07, 2022 07:30AM

Awakn Life Sciences Initiates Follow-On Behavioral Study to Focus on Gambling Disorder

Jun 02, 2022 07:30AM

Re: Awakn Life Sciences Provides Shareholder Update on Three Operational Ketamine-Assisted Therapy Clinics in the UK and Norway

Jun 01, 2022 05:46AM

Re: Awakn Life Sciences to Participate in Upcoming May 2022 Conferences

Jun 01, 2022 05:45AM

Awakn Life Sciences Files Patent Cooperation Treaty (PCT) Application for the Treatment of Behavioral Addictions

May 26, 2022 07:30AM